MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy

Mostafa Abdelsalam1, A M Wahab1, Maysaa El Sayed Zaki2

  • 1Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Abstract

Insights

MicroRNA-451 shows potential as an early diagnostic marker for diabetic nephropathy, offering higher sensitivity and specificity than traditional markers for chronic kidney disease. This microRNA can aid in early detection and management of kidney complications in diabetes patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Nephrology

Background:

  • Diabetes mellitus is a primary cause of end-stage renal disease globally.
  • Microalbuminuria is a key diagnostic marker for diabetic nephropathy but lacks early diagnostic sensitivity.
  • MicroRNAs are emerging as potential early diagnostic markers and therapeutic targets for diabetic nephropathy progression.

Purpose of the Study:

  • To evaluate microRNA-451 as an early diagnostic biomarker for diabetic nephropathy.
  • To compare microRNA-451 expression levels with traditional markers of kidney function in type 2 diabetes patients.

Main Methods:

  • Ninety patients with type 2 diabetes and 30 controls were included.
  • Real-time PCR was used to measure microRNA-451 expression in blood and plasma.
  • Serum creatinine, urinary albumin, and estimated glomerular filtration rate (eGFR) were assessed as standard markers.

Main Results:

  • Significant differences in serum creatinine, eGFR, and microRNA-451 levels were observed between diabetic patients and controls (p=0.0001).
  • Lower eGFR (<60 ml/min/1.73 m²) correlated with higher plasma microRNA-451 and lower urinary microRNA-451 (p=0.0001).
  • Plasma and urinary microRNA-451 demonstrated high sensitivity and specificity for detecting chronic kidney disease in diabetic nephropathy.

Conclusions:

  • MicroRNA-451 is a promising early biomarker for chronic kidney disease in diabetic nephropathy.
  • Its high sensitivity and specificity suggest a valuable role in early diagnosis and disease monitoring.
  • MicroRNA-451 may contribute to better management strategies for diabetic kidney disease.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
414
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
91
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
184
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
415
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
245